These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

748 related items for PubMed ID: 3317066

  • 1. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.
    Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A.
    Nature; ; 330(6149):662-4. PubMed ID: 3317066
    [Abstract] [Full Text] [Related]

  • 2. Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia.
    Fong Y, Tracey KJ, Moldawer LL, Hesse DG, Manogue KB, Kenney JS, Lee AT, Kuo GC, Allison AC, Lowry SF.
    J Exp Med; 1989 Nov 01; 170(5):1627-33. PubMed ID: 2809510
    [Abstract] [Full Text] [Related]

  • 3. Cachectin: a hormone that triggers acute shock and chronic cachexia.
    Tracey KJ, Lowry SF, Cerami A.
    J Infect Dis; 1988 Mar 01; 157(3):413-20. PubMed ID: 3278061
    [Abstract] [Full Text] [Related]

  • 4. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog.
    Tracey KJ, Lowry SF, Fahey TJ, Albert JD, Fong Y, Hesse D, Beutler B, Manogue KR, Calvano S, Wei H.
    Surg Gynecol Obstet; 1987 May 01; 164(5):415-22. PubMed ID: 3576418
    [Abstract] [Full Text] [Related]

  • 5. Metabolic responses to cachectin/TNF. A brief review.
    Tracey KJ, Cerami A.
    Ann N Y Acad Sci; 1990 May 01; 587():325-31. PubMed ID: 2193578
    [Abstract] [Full Text] [Related]

  • 6. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T, Baumgartner JD, Glauser MP.
    Prog Clin Biol Res; 1991 May 01; 367():141-59. PubMed ID: 1924424
    [Abstract] [Full Text] [Related]

  • 7. Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNF alpha).
    Hinshaw LB, Tekamp-Olson P, Chang AC, Lee PA, Taylor FB, Murray CK, Peer GT, Emerson TE, Passey RB, Kuo GC.
    Circ Shock; 1990 Mar 01; 30(3):279-92. PubMed ID: 2178801
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody.
    Taylor FB, Chang A, Ruf W, Morrissey JH, Hinshaw L, Catlett R, Blick K, Edgington TS.
    Circ Shock; 1991 Mar 01; 33(3):127-34. PubMed ID: 2044206
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. TNF-alpha and cyclooxygenase metabolites do not modulate C. albicans septic shock with disseminated candidiasis.
    Matuschak GM, Klein CA, Tredway TL, Schilly DR, Lechner AJ.
    J Appl Physiol (1985); 1993 May 01; 74(5):2432-42. PubMed ID: 8335578
    [Abstract] [Full Text] [Related]

  • 12. [Cachectin or TNF (tumor necrosis factor): clinical implications].
    Romieu M, Riche F, Bousseau A, Szekeli B, Schurando P, Briard C, Payen D.
    Ann Fr Anesth Reanim; 1990 May 01; 9(6):525-35. PubMed ID: 2278419
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tumor necrosis factor (cachectin) in the biology of septic shock syndrome.
    Tracey KJ.
    Circ Shock; 1991 Oct 01; 35(2):123-8. PubMed ID: 1777947
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tumour necrosis factor (cachectin) and other cytokines in septic shock: a review of the literature.
    Dofferhoff AS, Vellenga E, Limburg PC, van Zanten A, Mulder PO, Weits J.
    Neth J Med; 1991 Aug 01; 39(1-2):45-62. PubMed ID: 1961351
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of monoclonal antibody against tumor necrosis factor alpha in an endotoxemic baboon model.
    Emerson TE, Lindsey DC, Jesmok GJ, Duerr ML, Fournel MA.
    Circ Shock; 1992 Oct 01; 38(2):75-84. PubMed ID: 1423924
    [Abstract] [Full Text] [Related]

  • 18. Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-alpha in experimental gram-negative shock.
    Silva AT, Bayston KF, Cohen J.
    J Infect Dis; 1990 Aug 01; 162(2):421-7. PubMed ID: 2373872
    [Abstract] [Full Text] [Related]

  • 19. Release of endothelin in relation to tumor necrosis factor-alpha in porcine Pseudomonas aeruginosa-induced septic shock.
    Han JJ, Windsor A, Drenning DH, Leeper-Woodford S, Mullen PG, Bechard DE, Sugerman HJ, Fowler AA.
    Shock; 1994 May 01; 1(5):343-6. PubMed ID: 7743336
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleukin-6 and neutrophil elastase.
    Jansen PM, Pixley RA, Brouwer M, de Jong IW, Chang AC, Hack CE, Taylor FB, Colman RW.
    Blood; 1996 Mar 15; 87(6):2337-44. PubMed ID: 8630396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.